Scollard David M, Martelli Celina M T, Stefani Mariane M A, Maroja Maria de Fatima, Villahermosa Laarni, Pardillo Fe, Tamang Krishna B
National Hansen's Disease Programs, Baton Rouge, Louisiana; Federal University of Goias, Institute of Tropical Pathology and Public Health, Goias, Brazil; Federal University of Pernambuco, Tropical Medicine Department, Recife, Pernambuco, Brazil; Fundação de Dermatologia Tropical Alfredo da Matta, Manaus, Amazonas, Brazil; Leonard Wood Memorial Center for Leprosy Research, Cebu, Republic of The Philippines; Lalgadh Leprosy Hospital and Services Center, Dhanusha District, Nepal
National Hansen's Disease Programs, Baton Rouge, Louisiana; Federal University of Goias, Institute of Tropical Pathology and Public Health, Goias, Brazil; Federal University of Pernambuco, Tropical Medicine Department, Recife, Pernambuco, Brazil; Fundação de Dermatologia Tropical Alfredo da Matta, Manaus, Amazonas, Brazil; Leonard Wood Memorial Center for Leprosy Research, Cebu, Republic of The Philippines; Lalgadh Leprosy Hospital and Services Center, Dhanusha District, Nepal.
Am J Trop Med Hyg. 2015 Jan;92(1):108-14. doi: 10.4269/ajtmh.13-0221. Epub 2014 Dec 1.
The objective of this study was to ascertain risk factors for complications (reactions or neuritis) in leprosy patients at the time of diagnosis in three leprosy-endemic countries. Newly diagnosed patients were enrolled in Brazil, the Philippines, and Nepal, and risk factors for reactions and neuritis were assessed using a case-control approach: "cases" were patients with these complications, and controls were patients without complications. Of 1,972 patients enrolled in this study, 22% had complications before treatment. Type 1 reaction was diagnosed in 13.7% of patients, neuritis alone in 6.9.%, and type 2 reaction in 1.4%. The frequency of these complications was higher in Nepal, in lepromatous patients, in males, and in adults versus children. Reactions and neuritis were seen in patients at diagnosis, before treatment was started. Reactions were seen in adults and children, even in patients with only a single lesion. Neuritis was often present without other signs of reaction. Reactions and neuritis were more likely to occur in lepromatous patients, and were more likely to be seen in adults than in children.
本研究的目的是确定三个麻风病流行国家中麻风病患者在诊断时出现并发症(反应或神经炎)的风险因素。在巴西、菲律宾和尼泊尔招募新诊断的患者,并采用病例对照方法评估反应和神经炎的风险因素:“病例”为出现这些并发症的患者,对照为未出现并发症的患者。在本研究纳入的1972例患者中,22%在治疗前出现并发症。13.7%的患者被诊断为1型反应,6.9%为单纯神经炎,1.4%为2型反应。尼泊尔、瘤型患者、男性以及成人(相对于儿童)中这些并发症的发生率更高。在诊断时、开始治疗前,患者中就出现了反应和神经炎。成人和儿童中均出现了反应,即使是仅有单个皮损的患者。神经炎常单独出现,无其他反应体征。反应和神经炎更易发生于瘤型患者,且成人比儿童更易出现。